Markus Otto

University Name

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

ORCID

Google Scholar

Articles (21)

Criminal Behavior in Frontotemporal Dementia: A Multimodal MRI Study

Article Link

Year:

2025

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis

Article Link

Year:

2025

Implementing Blood Biomarkers in Stroke Research and Clinical Practice

Article Link

Year:

2025

Accuracy of blood-based neurofilament light to different genetic frontotemporal dementia from primary psychiatric disorders

Article Link

Year:

2025

Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases

Article Link

Year:

2025

Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of <i>APOE</i> ε4

Article Link

Year:

2025

Annual level changes of serum neuronal and glial biomarkers in a German professional football club

Article Link

Year:

2025

CSF synaptic biomarkers and cognitive impairment in multiple sclerosis

Article Link

Year:

2025

Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia

Article Link

Year:

2025

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using a novel assay for the detection of neurofilament medium chain

Article Link

Year:

2025

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

Article Link

Year:

2023

A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity

Article Link

Year:

2023

A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases

Article Link

Year:

2023

Blood beta-synuclein is related to amyloid PET positivity in memory clinic patients

Article Link

Year:

2023

Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

Article Link

Year:

2023

Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease

Article Link

Year:

2023

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood

Article Link

Year:

2023

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

Article Link

Year:

2023

Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia

Article Link

Year:

2023

High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease

Article Link

Year:

2023

Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181

Article Link

Year:

2022

Collaborators (13)

Nico Scherf

Max Planck Institute for Human Cognitive and Brain Sciences

GERMANY

Arabella Bouzigues

University College London

UNITED KINGDOM

Matthias Schroeter

Professor

Max Planck Institute for Human Cognitive and Brain Sciences

GERMANY

Lize Jiskoot

Assistant professor

Erasmus University Rotterdam

NETHERLANDS

Marco Bucci

Karolinska Institutet

SWEDEN

Lucilla Parnetti

Professor of Neurology

University of Perugia

ITALY

Lorenzo Barba

Martin Luther University Halle-Wittenberg

GERMANY

Karsten Mueller

Max Planck Institute for Human Cognitive and Brain Sciences

GERMANY

Lorenzo Gaetani

University of Perugia

ITALY

Johannes Levin

Professor for Clinical Neurodegeneration

Ludwig-Maximilians-Universität München

GERMANY

Giovanni Bellomo

University of Perugia

ITALY

Robert Jr Laforce

Professeur agrégé de clinique

Laval University

CANADA

Patrick Oeckl

GERMANY

Markus Otto

Research Interests

Explore related searches

Contact this professor

Articles (21)

Criminal Behavior in Frontotemporal Dementia: A Multimodal MRI Study

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis

Implementing Blood Biomarkers in Stroke Research and Clinical Practice

Accuracy of blood-based neurofilament light to different genetic frontotemporal dementia from primary psychiatric disorders

Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases

Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of <i>APOE</i> ε4

Annual level changes of serum neuronal and glial biomarkers in a German professional football club

CSF synaptic biomarkers and cognitive impairment in multiple sclerosis

Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using a novel assay for the detection of neurofilament medium chain

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity

A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases

Blood beta-synuclein is related to amyloid PET positivity in memory clinic patients

Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia

High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease

Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181

Collaborators (13)

Nico Scherf

Arabella Bouzigues

Matthias Schroeter

Lize Jiskoot

Marco Bucci

Lucilla Parnetti

Lorenzo Barba

Karsten Mueller

Lorenzo Gaetani

Johannes Levin

Giovanni Bellomo

Robert Jr Laforce

Patrick Oeckl

How do I reach out?

Meet Kite AI